Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NITE

Nightstar Therapeutics (NITE) Stock Price, News & Analysis

Nightstar Therapeutics logo

About Nightstar Therapeutics Stock (NASDAQ:NITE)

Advanced Chart

Key Stats

Today's Range
$31.45
$31.54
50-Day Range
$25.41
$25.41
52-Week Range
$9.59
$29.55
Volume
1,092 shs
Average Volume
185,808 shs
Market Capitalization
$1.06 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NITE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nightstar Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NITE Stock News Headlines

Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
Knight Therapeutics price target lowered to C$6.25 from C$6.75 at Stifel
NITE The Nightview ETF
Thank you for supporting The Big Night In
See More Headlines

NITE Stock Analysis - Frequently Asked Questions

Nightstar Therapeutics PLC (NASDAQ:NITE) announced its earnings results on Tuesday, November, 13th. The company reported ($0.27) EPS for the quarter, topping the consensus estimate of ($0.40) by $0.13.

Nightstar Therapeutics (NITE) raised $76 million in an IPO on Thursday, September 28th 2017. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Jefferies, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO and Wedbush PacGrow and Chardan were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nightstar Therapeutics investors own include Canopy Growth (CGC), Cronos Group (CRON), OncoMed Pharmaceuticals (OMED), Portola Pharmaceuticals (PTLA), Ligand Pharmaceuticals (LGND), Neurocrine Biosciences (NBIX) and Sangamo Therapeutics (SGMO).

Company Calendar

Last Earnings
11/13/2018
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:NITE
Fax
N/A
Employees
47
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$36.86 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$5.89 per share
Price / Book
5.34

Miscellaneous

Free Float
N/A
Market Cap
$1.06 billion
Optionable
Not Optionable
Beta
2.84
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:NITE) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners